McR-1 and OXA-48 in Vivo Acquisition in KPC-Producing Escherichia Coli After Colistin Treatment

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02540-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

First Report of OXA-48 Carbapenemase-Producing Escherichia Coli in Taiwan

Antimicrobial Resistance and Infection Control
PharmacologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2015English

Prevalence of Colistin Resistance Gene McR-1 and Absence of McR-2 in Escherichia Coli Isolated From Healthy Food-Producing Animals in Japan

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

McR-1 and blaKPC-3 in Escherichia Coli Sequence Type 744 After Meropenem and Colistin Therapy, Portugal

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2017English

McR-1 Facilitated Selection of High-Level Colistin Resistant Mutants in Escherichia Coli

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Novel Plasmid-Mediated Colistin Resistance Gene McR-3 in Escherichia Coli

mBio
VirologyMicrobiology
2017English

Detection of the McR-1 Gene in Colistin Resistant Escherichia Coli From Retail Meat in Japan

Microbiology and Immunology
VirologyImmunologyMicrobiology
2017English

Microbial Resistance to Colistin in Consequence of Mutations in the McR-1 Gene of Escherichia Coli

Biomarkers and Applications
2018English

Colistin Resistance Gene McR-1 and pHNSHP45 Plasmid in Human Isolates of Escherichia Coli and Klebsiella Pneumoniae

The Lancet Infectious Diseases
Infectious Diseases
2016English

High Prevalence of Colistin-Resistant Escherichia Coli With Chromosomally Carried McR-1 in Healthy Residents in Vietnam

mSphere
MicrobiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy